Cholesterol boosts the memory of the immune system

December 24, 2012, Albert Ludwigs University of Freiburg
In a naive cell (left), the receptors (blue) on the membrane are arranged individually. Pathogens (yellow) must bind to many receptors in order to activate the immune defense. In a memory cell (right), the receptors are joined together by cholesterol (red). When a pathogen binds one receptor of a cluster, all of the receptors within the cluster are activated. © Schame

The memory of the human immune system is critical for the development of vaccines. Only if the body recognizes a pathogen with which it has already come into contact in the case of a second infection, the immune system can combat it more effectively than it did the first time. The Freiburg immunobiologist Prof. Dr. Wolfgang Schamel from the Institute of Biology III of the University of Freiburg and his colleagues have succeeded in demonstrating how the memory of the immune system functions. Their findings have now been published in the journals Immunity and Journal of Biological Chemistry (JBC).

The immune system becomes acquainted with a pathogen during an initial infection and understands that it must be combated. When the T cell receptors of the immune system come across the same pathogen a second time, they are much more sensitive toward them than during the first encounter, and it thus takes less to activate the immune system. It was previously unclear why the receptors become more sensitive.

In 2011, Schamel's research group and a team led by Prof. Dr. Balbino Alarcon from the Autonomous University of Madrid, Spain, found the answer to this fundamental question. In a publication in the journal Immunity, they showed that the increased sensitivity is caused by a clustering of the receptors: In a naive cell that has not yet met the pathogen, the receptors are arranged individually on the , each fending for itself. A large number of receptors thus needs to be confronted by a large number of pathogens in order for the immune system to react. In a so-called memory cell, which remembers the pathogen, the receptors are arranged in groups on the membrane. When a pathogen binds to a receptor from a cluster, all of the receptors within the cluster are activated at once. This makes the more sensitive.

Now, as reported in the journal JBC, a team of researchers in Freiburg under Schamel and Prof. Dr. Rolf Schubert, professor for pharmaceutical technology and biopharmaceutics at the Institute of Pharmaceutical Sciences of the University of Freiburg, have succeeded in demonstrating how a cell forms these receptor clusters. The critical factors for the success of this endeavor were Schamel's expertise in biochemical research on T and Schubert's expertise in the production of liposomes. The collaboration between the two teams was made possible by a project funded by BIOSS Centre for Biological Signalling Studies, a Cluster of Excellence at the University of Freiburg.

Dr. Eszter Molnár, a postdoctoral researcher in Schamel's team, and Dr. Martin Holzer from Schubert's research group isolated the receptors and reconstructed them in a synthetic membrane. After one and a half years of work, the scientists achieved a breakthrough: They discovered that the composition of the lipids of a membrane is responsible for the clustering of the receptors. The lipid composition of a naive cell differs from that of a memory cell. Cholesterol is the key factor in this process, as it is present in higher concentrations in a . This higher concentration of cholesterol leads to the aggregation of receptors, because the cholesterol joins them together like glue.

Schamel and Schubert are members of the Freiburg Cluster of Excellence BIOSS Centre for Biological Signalling Studies. Schamel is also a member of the Spemann Graduate School of Biology and Medicine and the Center for Chronic Immunodeficieny of the Freiburg University Medical Center and director of the EU network SYBILLA, which also supported this project.

Explore further: Blood cancer cells initiate signalling cascade

More information: Increased Sensitivity of Antigen-Experienced T Cells through the Enrichment of Oligomeric T Cell Receptor Complexes, Immunity, Volume 35, Issue 3, 375-387, 08 September 2011, www.cell.com/immunity/retrieve … ii/S1074761311003566

Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering, First Published on October 22, 2012, doi: 10.1074/jbc.M112.386045 December 14, 2012 The Journal of Biological Chemistry, 287, 42664-42674. http://www.jbc.org/cgi/doi/10.1074/jbc.M112.386045

Related Stories

Blood cancer cells initiate signalling cascade

August 13, 2012
Researchers in the group of Prof. Dr. Hassan Jumaa, Centre for Biological Signalling Studies (BIOSS) of the University of Freiburg, Department for Molecular Immunology, have identified a new mechanism that causes immune cells ...

Recommended for you

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

Immunosuppressive cells in newborns play important role in controlling inflammation in early life

January 15, 2018
New research led by The Wistar Institute, in collaboration with Sun Yat-sen University in China, has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.